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Zusammenfassung
Psychologie als «Mutterwissenschaft» für Psychotherapie 
und psychische Gesundheit
Psychologie als Wissenschaft bietet ein breites Spektrum an 
Theorien, Grundlagen und methodischen Ansätzen, um 
psychische Gesundheit, normale und gestörte Funktionen 
und Verhaltensweisen sowie psychische Störungen zu er-
forschen und zu «verstehen». Auf dieser Grundlage haben 
sich in der Klinischen Psychologie vielfältige effektive, psy-
chologisch begründete Interventionen für die Prävention, 
Behandlung und Rehabilitation von psychischen Störungen 
ausdifferenziert. Damit ist die Psychologie als «Mutterwis-
senschaft» der Psychotherapie und psychotherapeutische 
Praxis anzusehen. Der Beitrag versucht auf der Grundlage 
einer Stärken-/Schwächen-Analyse der psychologischen 
Forschung diejenigen Themenbereiche zu definieren, die für 
Erkenntnisfortschritte bei psychischen Störungen und die 
psychotherapeutische Interventionsforschung besonders 
vielversprechend sein könnten. Dysfunktionale bzw. abwei-
chende Verhaltensweisen wie auch psychische Störungen 
lassen sich als entwicklungsbezogene Störungen psycholo-
gischer Funktionen und Prozesse und damit assoziierter 
neurobiologischer und genetischer Prozesse konzeptualisie-
ren. Für eine verbesserte Identifikation von zentralen Vulne-
rabilitäts- und Risikofaktoren sowie ätiologisch relevanten 
Schlüsselprozessen wird ein integratives translationales 
Modell vorgeschlagen, welches die Grundlagen- und expe-
rimentelle Forschung mit klinischer Forschung, Translation 
und Public-health-Implikationen verknüpft. Damit soll auf 
der einen Seite eine stringentere Ableitung gezielter Inter-
ventionen erleichtert werden, andererseits aber auch eine 
bessere Identifikation der zentralen Wirkfaktoren und Wirk-
prozesse psychologischer Therapien ermöglicht werden. 
Basierend auf einem europäischen Experten-Beratungspro-
zess wird ein EU-Programm ‘The science of behavior 
change’ angeregt. 
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Summary
The psychological sciences offer a large spectrum of theo-
ries, principles, and methodological approaches to under-
stand mental health, normal and abnormal functions and 
behaviours, as well as mental disorders. Based on contin-
ued research progress, psychology has derived a wide 
range of effective interventions for behaviour change and 
the prevention, treatment and rehabilitation of mental disor-
ders. Thus, psychology and clinical psychology in particular 
should be regarded as the ‘mother’ science for psychothera-
py and psychotherapeutic practice. This paper provides a 
selective overview of the scope, strengths and gaps in psy-
chological research to depict the advances needed to in-
form future research agendas on mental disorders and psy-
chological interventions in the context of psychotherapy. 
Most maladaptive health behaviours and mental disorders 
can be conceptualised as the result of developmental dys-
functions of psychological functions and processes, and as 
associated neurobiological and genetic processes in interac-
tion with behaviour and the environment. An integrative 
translational model, linking basic and experimental re-
search with clinical research and population-based prospec-
tive-longitudinal studies is proposed for improving identifi-
cation of critical core vulnerability and risk factors and core 
pathogenic mechanisms. The proposed framework is ex-
pected to allow a more stringent delineation of targeted 
preventive and therapeutic psychological interventions and 
an optimisation and better understanding of cognitive-be-
havioural therapies and other psychological interventions. 
Based on a European consultation process, a ‘Science of 
Behaviour Change’ programme with the promise of im-
proved diagnosis, treatment and prevention of both health-
risk behaviour constellations and mental disorders is pro-
posed.
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Core Role of Psychological Sciences for  
Psychotherapy, the Understanding of Mental  
Disorders and the Promotion of Mental Health
Irrespective of the interdisciplinary nature of the mental health 
field, psychology is the ‘mother’ science for mental health and 
mental disorders and the essential science platform for both the de-
velopment and the practice of interventions in the mental health 
field. Current shifts in research emphasis from traditional highly 
complex and dynamic psycho-bio-social behavioural interaction 
concepts to complementary putative causal neurobiological and 
broader biomedical research models have not changed the situa-
tion. In fact there is increasing convergence and synergy between 
biomedical and psychological research on mental health and men-
tal disorders. Both fields, psychology and the biomedical disci-
plines, study the same or related phenomena with increasingly 
similar and complementary approaches and methods. Thus, it is 
not surprising that appraisals of strengths and weaknesses in both 
fields often arrive at the same conclusions [Schumann et al., 2014; 
Wittchen, 2014; Wittchen et al., 2014a]. Despite this continued 
trend of growing convergence and synergy, it seems to be timely 
not only to emphasize the unique contributions of the psychologi-
cal sciences with regard to their traditions, theories, principles, and 
methods, but also to critically appraise their unique value, potential 
and impact on improving future research within the next few dec-
ades, for example with regard to a better understanding of the de-
terminants and core mechanisms of mental health and mental dis-
orders and the experimental and clinical derivations of improved 
interventions. Such an appraisal is of particular relevance for the 
field of psychotherapy or, more broadly, psychological interven-
tions in general, as empirical evidence from clinical research sug-
gests that cognitive-behavioural treatments (CBTs) are currently 
the most effective first-line treatments for many mental health 
problems and disorders [Butler, 2006; Emmelkamp et al., 2014]. 
However, the development of the psychotherapy field has been 
appraised as critical and some [Emmelkamp et al., 2014] have even 
suggested that psychotherapy research needs rebooting. For exam-
ple, even after 25 years of research we still do not know why and 
how CBT works, or how to diminish the still-widening gap regard-
ing the way psychological treatments are delivered in research set-
tings as opposed to routine care. Under the still-considerable influ-
ence of historically rooted encapsulated schools of thought and in-
creasing pressures due to the professionalization of psychotherapy, 
the field of psychotherapy seems to be confronted with the danger 
of losing its science basis and its essential roots in the psychological 
sciences. Latest progress in crucial basic, applied and clinical re-
search in the psychological and neurobiological disciplines are fre-
quently neither recognized nor translated into improved models or 
improved interventions and service delivery. 
Because of this critical situation the EU has recently launched, 
supported and funded a major initiative called the ‘Roadmap for 
Mental Health Research’ [ROAMER, 2013; Haro et al., 2014]. As 
part of this project, a critical appraisal of the actual situation was 
conducted with the goal of providing guidance for an integrated 
and participatory roadmap for mental health research in Europe 
from the perspective of the Psychological Sciences. In this paper, 
we selectively summarize several core findings and conclusions of 
this programme (for a full discussion see the ROAMER supple-
ment edition of the Int J Methods Psychiatr Res 2014; 23,1–101). 
Relationship of Psychology and Psychotherapy
Psychology can broadly be defined as an academic and applied 
discipline that involves the scientific study of (a) basic psychologi-
cal functions such as perception, cognition, attention, emotion, 
motivation (b) complex psychological processes such as decision 
making, volition and behaviour control (c) their neural and bio-
logical underpinnings, as well as (d) personality, behaviour and in-
terpersonal relationships. Psychology covers normal mental func-
tions plus behaviours and addresses the questions of when, why 
and how they can become dysfunctional. Thus, psychology covers 
mental health and abnormal functions and behaviours, as found in 
mental disorders, with the goal of understanding individuals, 
groups and social systems. Psychology has been described as a ‘hub 
science’ [Cacioppo, 2007] with psychological findings linked to re-
search and perspectives from the social sciences, natural sciences, 
medicine, and the humanities, such as philosophy. Over the past 
few centuries, the field of psychology has undergone several theo-
retical paradigm shifts (i.e. structuralism, functionalism, psychoa-
nalysis, behaviourism, cognitivism) and is currently typically struc-
tured in subfields of which biological, experimental, developmental 
and clinical psychology have become closer to the biomedical field 
[Haslam and Lusher, 2011]. Depending on different national or re-
gional scientific traditions, psychological and psychotherapy re-
search can, however, also be grouped under social sciences, natural 
sciences or biomedical sciences, etc. In fact, in some countries 
terms like behavioural neuroscience or cognitive-affective neuro-
science are used almost synonymously, leading to the field being 
denoted as psychological sciences.
Key corollaries of the psychological sciences are, e.g.: 
– As compared to the biomedical field, the psychological sciences 
more explicitly emphasize a comprehensive interactional bio-
psycho-social approach to understanding and predicting a 
broad construct of ‘behaviour’ that refers to neurobiological, 
cognitive, affective and social-behavioural units of analyses – 
and should not be misunderstood as denoting simply open 
motor behaviour.
– The relative role of biological, psychological and particularly so-
cial-environmental variables and their dynamic interplay in pro-
moting normal and abnormal behaviour is examined within a 
‘dimensional’ rather than a ‘categorical’ (diagnostic) approach.
– Consistent with a broad construct of behaviour, psychological 
research uses a variety of specific experimental and empirical 
methods (qualitative and quantitative, subjective and objective) 
and paradigms in human and animal research to observe causal 
and correlational relationships between psychosocial, environ-
mental, psychological and biological variables.
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Psychological sciences emphasize environmental variables and a 
developmental perspective by appreciating the highly dynamic in-
terplay over time, e.g. in psychological constructs of vulnerability 
– stress models and interactional constructs such as resilience and 
coping to understand behaviour change and its determinants. 
Defining Psychotherapy
Based on such principles, constructs and methods, the science 
of psychology has also provided a set of unique methods and tech-
niques for psychological interventions (i.e. psychotherapy) with 
the goal of preventing, treating and rehabilitating dysfunctional be-
haviour and mental disorders. Within this context of psychology, 
psychotherapy is defined as an applied clinical psychological do-
main discipline, dealing, generally spoken, with psychological 
treatments and interventions. More precisely psychotherapy has 
been defined as ‘clinically relevant, empirically supported interven-
tions of any type that are based on knowledge and expertise in the 
psychological sciences using psychological methods and means (as 
opposed to drugs as in psychiatry), typically by communication 
and/or behavioural exercises’ [Wittchen and Hoyer, 2011, p 4]. 
This definition includes a large group of methods and ap-
proaches, developed to address the needs of patients and groups of 
patients with mental disorders or mental health problems, as well 
as their networks of support (e.g., partner and family) and covers 
prevention, treatment and rehabilitation in patients of all ages. Psy-
chological treatments and interventions might range from highly 
sophisticated psychotherapy, delivered by specialized psychothera-
pists, to the application of specific behavioural techniques as part 
of a broader treatment plan (e.g., psychoeducation or motivational 
interviewing) by any health provider, including web-based and e-
health applications, whenever the criteria of the above definition 
are met and efficacy and/or effectiveness is established by rand-
omized clinical trials or equivalent designs [van der Feltz-Cornelis 
and Adèr, 2000]. Because dysfunctional behaviour (also denoted in 
the literature as abnormal or clinically relevant behaviour or syn-
dromes of mental disorders) has large and pervasive effects on 
health and ill health development and outcomes, there is a broad 
consensus in the scientific community that there is still vital to im-
prove research with the goal to provide a better understanding of 
–  the mechanisms underlying adaptive and dysfunctional 
behaviour, 
– the developmental pathways and trajectories leading to dys-
functional and clinically significant behaviours as well as the de-
terminants for these trajectories,
– the identification, by whatever means these determinants can be 
targeted and systematically influenced, and
– the mechanisms of behaviour change with regard to the promo-
tion of normal, adaptive health as well as the reduction or pre-
vention of dysfunctional and clinically significant behaviours as 
in mental disorders.
To reach these goals the ROAMER expert group [Schumann et 
al., 2014; Wittchen et al., 2014a] concluded that the currently frag-
mented research field needs to be bundled under a broader com-
prehensive umbrella of a ‘Science of Behaviour’ programme in psy-
chology and mental health research in general. For substantial pro-
gress to be made, the group suggested 3 essential steps: First, the 
adoption of an integrative conceptual framework; second, research 
to identify the most promising targets and procedures; and third, 
the improved translation of new findings and methods into a psy-
chotherapy translational research agenda.
Developing Conceptual Frameworks to Identify  
Aetiopathogenic Factors and Mechanisms to Derive 
Novel Therapeutic Targets
There is consensus that improved knowledge about the core de-
terminants of mental health and mental disorders is essential to 
identify the most promising therapeutic targets and procedures. 
There is also consensus that most mental disorders can be best 
characterized by their developmental and processual nature 
[Wittchen et al., 2014a,b]. To reach this goal, for internalizing dis-
orders, examples of core questions that need to be answered in-
clude: Why are many people able to cope with traumatic stress and 
anxiety, while others develop increasingly severe avoidance behav-
iour resulting in anxiety disorders and their sequelae, such as help-
lessness and depression or substance use and eating disorders? 
What drives humans to develop and to maintain health risk behav-
iours such as harmful drinking and eating or smoking? Why are 
many individuals able to control their substance use or eating be-
haviours, while others develop a persistent maladaptive behaviour-
al pattern ultimately leading to dependence or obesity, consequen-
tial disease and disability, and eventually a loss of control over their 
life? And, more generally: What are the critical trajectories from 
maladaptive behaviours to (mental) disorders as defined in classi-
ficatory diagnostic systems, such as the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) [APA, 2000, 2013] or the In-
ternational Classification of Diseases [WHO, 1991]? Can we modi-
fy critical developmental pathways by directly targeting such 
mechanisms?
From a psychological and cognitive-affective neuroscience per-
spective, such health-risk behaviours and mental disorders can be 
conceptualized as the procedural and developmental outcome of 
complex interactions of individual genetic predispositions with the 
environment and as neurobiological, psychological and social pro-
cesses within ‘personal biographies’. The brain as the essential tar-
get structure is shaped by genetic factors, development, environ-
ment and experience in multiple, highly complex and probably in-
dividual ways. All human actions including adaptive and dysfunc-
tional decision making involved in health-risk behaviour and 
common mental disorders are the result of complex interactions 
between: (1) higher cognitive processes such as the anticipation of 
long-term consequences, the regulation of emotional impulses and 
the inhibition of habitual responses in favour of long-term goals; 
(2) complementary forms of learning and memory, and (3) basic 
emotional, reward-related, and motivational processes. Health-risk 
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behaviours and mental disorders also provide indirect evidence for 
latent shared mechanisms. These communal behavioural, cognitive 
and physiological features suggest the existence of similar aetio-
logical mechanisms, such as the ‘continued making of maladaptive 
choices even in the face of the desire to make a different choice’ as 
a defining diagnostic criterion [APA, 2000]. They frequently ‘bun-
dle together’, start predominantly early in life and escalate tempo-
rally in similar patterns. In this context, mental disorders can be 
conceptualized as yet insufficiently understood dysfunctions in 
basic psychological processes as well as ‘perturbations’ in brain 
functions at the cell and systems level. The former processes can be 
conceived as being centrally involved in the behavioural, cognitive-
affective and somatic symptoms currently used to define mental 
disorders. The latter ‘perturbations’ can broadly be described as 
various types of dysfunctions in complex structural and functional 
neural circuits for information processing. Appropriate experi-
mental psychological paradigms in combination with brain imag-
ing methods, supplemented by molecular and biochemical analy-
ses, allow examining the complex, plastic interactions and the con-
nectivity of brain regions for different functions. 
At present we still lack complete maps of such human circuitry 
dysfunctions. For many conditions, however, candidate models 
exist and serve as a starting point (e.g. addictive behaviours – in-
volvement of reward circuitries [Koob and Le Moal, 2001]; fear 
and anxiety disorders – abnormalities of the amygdala-based fear 
circuitry [Shin and Liberzon, 2010]). Corresponding candidate 
mechanisms at the behavioural level include aspects of cognitive 
control and volition, emotion regulation, meta-cognition, and de-
cision-related processes, such as evaluation, risk perception and 
temporal discounting. However, the diagnostic specificity, moder-
ating and even causal role of such highly complex ‘circuitry pertur-
bations’ in the evolution of mental disorders, persistent health-risk 
behaviours and associated clinical behavioural syndromes (e.g. adi-
positas, obesity) remain unclear. Despite impressive achievements 
in this area, we still lack answers to core questions [Goschke, 2014].
How do complementary cognitive, affective, and motivational 
systems interact dynamically, which proximal and distal variables 
(e.g. acute or chronic stress) modulate patterns of interactions 
among these systems, and how do stable patterns of system interac-
tions evolve as a result of genetic variation, developmental change, 
and learning?
Which mechanisms underlie transitions from adaptive cogni-
tive-behavioural patterns into maladaptive patterns of persistent 
health-risk behaviours or mental disorders? Are there critical de-
velopmental windows of vulnerability? Are cognitive dysfunctions 
(e.g. impaired volitional control) simply ‘constitutive markers’ or 
generalizable causal disease factors? How can effective change of 
dysfunctional behaviour patterns be induced and maintained by 
targeting such mechanisms?
One promising way to address such questions is to conceptual-
ize mental disorders as maladaptive developmental processes, in 
that they reflect complex interactions of individual genetic predis-
positions with environments within ‘personal biographies’ of psy-
chological dispositions, associated with characteristic changes in 
neural systems and circuitries. One might also hypothesize that 
processes responsible for the development of health-risk behav-
iours and the shaping of respective vulnerabilities can be conceptu-
alized on the same theoretical grounds and that both unique and 
cross-cutting pathways and mechanisms exist. Such an approach 
offers the opportunity of addressing core questions; however, such 
an endeavour involves addressing a number of critical issues con-
sidered below.
Cognitive-affective factors and action: There is a need for con-
certed efforts to examine experimentally the neurocognitive mech-
anisms underlying human behaviour and, for example, decision 
making. This requires a better knowledge of cognitive systems 
[Schumann et al., 2014], including modulating influences (i.e. 
stress [Schumann et al., 2014]) and developmental (see below) tra-
jectories of adaptive and maladaptive patterns, such as of decision 
making and action control, in non-clinical and clinical populations 
[Goschke, 2013].
Developmental mechanisms and pathways: Mental disorders 
and health-risk behaviours must be conceptualized as occurring on 
multiple time scales and thus as ‘developmental’ in a broad sense. 
The concerted growth of regulatory mechanisms in early ages is a 
prerequisite for personal autonomy, adaptive behaviour and sus-
tained mental health. The brain’s developmental plasticity in early 
ages along with prospective longitudinal evidence that the onset of 
most common mental disorders is centred in relatively small, pre-
dominantly early-time windows in the lifespan [Kessler et al., 2005; 
Beesdo-Baum and Knappe, 2012] renders a developmental psycho-
logical perspective essential. Further, determinants and modifiers 
of (mal-)adaptation might arise from genetic/epigenetic factors as 
well as from gene-environment interactions, all intersecting at the 
level of functional and structural neurobiological functioning dur-
ing development, progressing from early pre- and postnatal stages 
throughout the lifespan.
Stress and environment: There is overwhelming evidence that 
conditions of traumatic and chronic stress can significantly change 
the structure and functioning of brain circuits and significantly im-
pact gene expression and translation. Such plastic changes in pe-
ripheral physiology and neural activity are found to be linked to 
adverse health outcome, as characteristic differences in neuro-
transmitter systems, immune systems functions, and peripheral 
endocrine patterns follow stress exposition. Thus, acute and chron-
ic stress affect the developmental trajectory of health-risk behav-
iours in humans and animals. Use of cutting-edge psychoneuroen-
docrine methods are needed to understand the complex interac-
tion patterns of stress and ill-health behaviour in children, adoles-
cents, and adults. Innovative methods to measure ‘stress’ will 
propel our understanding of the mechanisms leading to health-risk 
behaviour and resulting morbidity.
Computational and other modelling approaches (e.g. trajectory, 
latent growth modelling): These are central for modelling complex 
interactions to reduce the enormous complexity because there are 
no simple ‘causal’ relationships. There is a lack of explicit (e.g. 
computational or connectionist) models of the mechanisms and 
dynamics of developmental change, which are needed for under-
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standing how nonlinear interactions among component processes 
on different levels of analysis give rise to emergent properties (e.g. 
nonlinear developmental trajectories, critical periods, stable pat-
terns of dysfunctional regulation).
Associated ‘reductionistic’ mechanistic basic research: Such re-
search is needed ultimately to identify and examine the nature of 
the characteristics of critical systems and putative causal mecha-
nisms. This means that such an overall strategy needs to be supple-
mented by stringent behavioural and biological studies. This ap-
plies to interactions of putative components within neural cells, 
cell systems and circuitries, within different psychological process-
es and between neural circuitry and psychological processes. Skilful 
data integration and modelling (systems biology, computational 
neuroscience) can help to reduce complexity so that specific hy-
potheses become testable in concrete biological or behavioural 
models, which in turn can feed back into the research design [e.g., 
Kraemer, 2014; Siegle et al., 2012]. 
Epidemiology and population genetics: Clinical samples have 
only limited value for investigating potentially causal interactions 
in many conditions. This is not only due to the fact that subjects 
sampled from clinical population are typically suffering for many 
years, but also due to confounding by selection bias, treatment ef-
fects and the presence of comorbid conditions that might have 
been developed as a consequence of prior clinical conditions. They 
also provide little information about normal and adaptive process-
es, protective factors or preventive targets, limiting their value 
when it comes to identifying protective factors and resilience. Use 
of the full range of options provided by descriptive and causal ana-
lytic epidemiological approaches to define cases/patients in all 
stages, as well as population genetics and developmental psycholo-
gy to define developmentally sensitive, prospective cohorts of rele-
vant pheno- and genotypes are thus mandatory to identify devel-
opmental and symptom pathways and their critical trajectories.
Clinical, treatment and translational perspective: Identifying the 
potentially causal or mediating role of such processes and interac-
tions over time promises a better understanding of when, how and 
why the evolved mechanisms might fail or become dysfunctional. 
Such insight can be seen as a precondition for testing similarities 
and differences in the evolution of specific behaviours and syn-
dromes and their malleability. More importantly, such improved 
understanding also provides the opportunity to identify potentially 
more promising targets of intervention that aim less on modifying 
common symptoms, but rather directly allow the underlying core 
vulnerabilities and core dysfunctional aetiological factors to be 
modified. This might have tremendous potential, e.g. for optimiz-
ing targets and form and dose of cognitive-behavioural interven-
tion in patients as well as preventive efforts.
Symptom Progression Models and an Integrative Translational  
Public Health Perspective
From an integrative translational perspective existing ‘symptom 
progression models’ are at least of great heuristic value (fig. 1). The 
existing descriptive models, although imperfect and still largely 
speculative, assume a systematic evolution of symptoms from ini-
tially transient to more persisting and pronounced expressions, 
seen as the result of critical interactions of vulnerabilities with en-
vironmental and experiential influences and their dysfunctional 
processing in developmentally sensitive periods. 
Identifying the Most Promising Targets
Empirically sound models are instrumental for defining starting 
points, for example with regard to questions like: ‘What are puta-
tive core dysfunctional process targets? What are the most critical 
‘trajectories’ in the developmental pattern? What is a promising 
and feasible strategy to modify the progression trajectories form 
early preclinical signs to clinically significant expressions. Such a 
targeted strategy not only has the potential of improving existing 
and deriving novel interventions that could be adapted to early 
preclinical and advanced clinical stages, but also has two evident 
additional advances. First, such an approach is likely to enhance 
the public health utility of research, because there is the premise 
that such early targeted intervention will be associated with a high-
er probability of substantially reducing the future burden. Second, 
this strategy will at least partially avoid the traditional ‘translational 
hurdles’ of the conventional approach (fig. 2). 
Procedural developmental modelling in representative samples of 
both low- and high-risk subjects and of clinical groups is required to 
identify: (1) the determinants of critical trajectories (e.g. adaptive to 
maladaptive, non-clinical to clinical), (2) specific and cross-cutting 
processes, and (3) novel ‘targeted’ interventions. It further carries 
the potential for greater research synergies across disciplinary 
boundaries, and adds considerable public health and translational 
utility, beyond major impact on diagnosis and treatment. 
As displayed in figure 2, such a strategy requires an iterative 
transdisciplinary multi-method approach in samples and cohorts 
starting with many questions as early as conception or (very) 
young age up to old age in order to 
– elucidate the ‘normative’ (adaptive) expressions of psychologi-
cal functions and processes, their neurobiological, molecular 
and genetic substrates, and their interaction by developmental 
Fig. 1. Examples for symptom progression models.
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stage in well-defined ‘normal’ populations with theory-driven, 
tailored task paradigms;
– model pathways and system interactions both at a structural 
level (e.g. latent trait and growth, reduction of complexity, 
‘higher order constructs’) and a ‘mechanistic’ level (e.g. circuit-
ry processes, computational neuroscience);
– validate, challenge and improve the emerging models by basic 
science experiments (e.g. cytological studies) to derive im-
proved models for further testing (e.g. systems biology);
– incorporate individual and contextual factors to determine how 
functions, processes and circuitries are developmentally influ-
enced by learning, plasticity, emotional traits, and stress;
– apply the derived models in defined risk cohorts to examine 
how, why, when and where system components are affected and 
prospectively associated with increased risk for onset; and
– test, ultimately, how and to which degree these dysfunctions 
can be altered by interventions that specifically target the un-
derlying mechanisms.
We recently – together with many colleagues – elaborated ten-
tatively matching research strategies for such an agenda using 4 
specific examples of syndromes and disorders, namely ‘stress, fear, 
avoidance and anxiety disorders’, ‘addictive behaviours’, ‘impulse 
control disorders’, and ‘eating and metabolic disorder’ [Wittchen 
et al., 2014a]. Some of the core goals and core challenges involved 
in such a programmatic process are depicted in table 1.
These examples make it clear that in order to make major pro-
gress in mental health research and mental disorders we have to 
redirect our current fragmented disciplinary research strategies to-Fig. 2. The conceptual framework.
Goals Challenges (advances needed)
Analysis of the development of  
adaptive and maladaptive  
mechanisms and modulators of  
decision making and behavioural  
control
How habitual, motivational, affective, and executive control systems interact dynamically and 
how this interaction is modulated by proximal and distal variables (e.g. acute/chronic stress); 
how stable patterns of interactions between motivational, emotional and executive-control  
systems evolve as a result of the interplay of learning, development, and genetic variation, and 
how inter-individual differences in intra-individual change patterns emerge;
which mechanisms underlie the transition from adaptive goal-directed behaviour into  
dysfunctional regulation patterns leading to maladaptive behavioural choice;
whether behavioural change and adaptive (e.g. health-promoting) behaviour can best be  
supported by strengthening volitional functions (e.g. the ability to maintain intentions in the 
face of competing habits or emotional temptations) or by enhancing motivational incentives  
associated with long-term goals (or whether both aspects need to be targeted).
Addictive behaviours and  
addiction
Strategically intermediate and long-term objectives might build on novel theoretical unified  
perspectives for addiction as ‘vulnerabilities’ in established ‘decision-making systems’ [Redish  
et al., 2008] and extensions thereof (e.g. temporal difference reinforcement learning).
Eating, eating disorders and  
neurometabolic conditions
Examination of common and specific psychological, neurological and circuitry dysfunctions 
across various forms of syndromes and disorders and in different stages of expression/develop-
mental stage may help to derive improved models and novel therapeutic targets and approaches;
although multiple candidate mechanisms have been proposed with symptom and diagnostic 
relevance for Anorexia Nervosa, evidence for other eating disorders and related phenomena are 
lacking;
Determination of whether leptin resistance develops in the homeostatic circuitry controlling  
appetite and, thereby, a similar resistance develops in the reward circuitry. If so, food may serve 
as a rewarding stimulus, independently of energy balance, and alteration of these mechanisms 
may facilitate understanding of obesity.
Stress, fear, avoidance and  
anxiety disorders
Despite the existence of various heuristic models, it is not known why, when and how which 
components of cognitive-behavioural treatment (CBT) are essential in promoting behaviour 
change. Neurobiological and particular fear-circuitry underpinnings of this method remain  
unclear. Improved understanding of such processes might have tremendous implications not 
only in improving treatment by optimizing the formal and content structure of CBT, but also  
for targeted prevention of anxiety-related reactions and behaviours, before the full syndrome  
is expressed clinically.
Table 1. Goals and 
challenges for selected 
behavioural problems 
and related mental dis-
orders
The conventional
approach
Normal, 
adaptive 
development
Dysfunctional
(illness/disorder)
Conception
birth
From vulnerabilities and early core process dysfunctions
in critical trajectories to the shaping of disorders
Personalized
medicine
Childhood/adolescence Adulthood and high age
I Public health benefit
early targeted interventions
II Treatment benefit
Translational hurdle 1
Clinical trials
Clinical practice
From patients to pathophysiology
Disease
Mechanisms
Translational hurdle 2
The Future 
approach?
Core
processes &
mechanisms
Evolution &
critical
trajectories
Novel targeted
early interventions
Pre-clinical stage:
Adaptive & maladaptive behavior
I. Targeted
early intervention in 
preclinical stages/risk groups
Targeted optimized
therapies
II. Targeted optimized therapeutic
intervention in clinical stages
Clinical-therapeutic stage:
optimized interventions
Targeted
treatment
Targeted
early
interventions
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wards a broader behavioural science focus. Most solutions to the 
complex problems of mental health require the synthesis of knowl-
edge and methods across various disciplines within a psychological 
framework. However, past barriers have made true interdiscipli-
nary approaches rare exceptions [Pellmar and Eisenberg, 2000]. 
The fragmentation and ‘disciplinary insularity’ of the mental health 
research field needs to be overcome by linkages among relevant 
biological, psychological, social and clinical approaches. Thus, only 
a concerted trans-disciplinary effort will be able to adequately ad-
dress the full scope of mental health, involving behavioural, clinical 
and neuroscience concepts using a multi-level, multi-measurement 
approach within a developmental framework. Our proposal refers 
in this context to similar conceptual frameworks, such as the one 
proposed by the NIMH Working Group on Child and Adolescent 
Mental Health [NAMHC, 2008] highlighting the critical develop-
mental transition points across the lifespan in order to link basic 
science findings with clinical and social aspects. 
Advancing Psychotherapy Research 
Against the background of the previous considerations regard-
ing psychological theories and models of mental health and disor-
ders, the following question arises: How can the painted perspec-
tive be brought into improved psychotherapy research? Given the 
current quite diffuse situation in research and practice of psycho-
therapy, one might also ask whether the time has come to reboot 
psychotherapy research altogether. Psychotherapy is rooted in 
many different traditions, conceptual models and ‘schools of think-
ing’, ranging from theoretically based approaches, such as psycho-
dynamic therapy, to more experimentally based psychological in-
terventions, such as CBT. Psychotherapy, although having some 
well-founded specific theories and models, research targets, meth-
ods and procedures, in many respects does not have an overarch-
ing scientific foundation. Clear conceptual frameworks that bring 
together the wide variety of findings, models and perspectives and 
essential linkages to basic psychological and neurobiological re-
search evidence are lacking. Further, attempts to develop common 
overarching integrative frameworks, such as proposals for empiri-
cally based ‘psychological therapies’ or a ‘unified treatment’ have 
not been successful so far. Thus, it is not surprising that there is a 
tremendous gap between psychotherapy methods as applied in 
well-controlled clinical trials and psychotherapy in routine care. In 
particular, it is disturbing that it is not clear what is meant when 
mental health interventions in real life are described as psychother-
apy or even CBT, because frequently neither the content, nor the 
form and structure of routine care psychotherapy matches to that 
done in well-controlled clinical studies. Nevertheless, in policy 
making we use the efficacy and effectiveness results of such trials as 
justification for the claim that psychotherapy works. This incoher-
ent picture of psychotherapy has created increasing confusion for 
policy makers and the public with regard to the scientific status of 
psychotherapy and the misconception that psychotherapy is little 
more than counselling. 
A Way forward to Reboot Psychotherapy Research?
Given the established efficacy and benefits of psychotherapy 
and CBT in clinical controlled trials, the time has come for con-
certed action to develop psychological interventions and psycho-
therapy further on the grounds of the psychological sciences. 
Without trying to be complete and without implying that current 
established psychotherapy research areas should be given up, we 
want to give a few examples how we can make major progress in 
this respect.
Focus on Principles of Behaviour Change Targeting Core 
Processes
In the preceding parts of this paper, we have emphasized the 
general strategies that seem to be timely and most promising, i.e. to 
focus on experimentally and empirically supported principles of 
behaviour change, and targeting the relevant core processes in-
volved in the aetiology and maintenance of mental disorders and 
mental health problems. Mental disorders can be regarded as 
‘functional and developmental’ in nature, as has been outlined 
above. Formally, we can conceptualize mental disorders in terms of 
(disturbances in) core psychological functions (attention, learning, 
memory, decision making, cognitive control, emotion regulation, 
etc.; see [Goschke, 2014]) or in terms of their meaning and func-
tion (e.g. a bias towards over-general autobiographical memory 
retrieval in depression, although detrimental for everyday problem 
solving, may help ward off unpleasant, traumatic or threatening 
memories; [Williams et al., 2007]). Although this innovative ap-
proach, mostly using interventions relying on ideas gleaned from 
experimental cognitive psychology, is still in its early developmen-
tal phase, it nevertheless has already provided some remarkable 
findings in clinical samples (e.g. memory specificity training for 
depression, see [Raes et al., 2009; Neshat-Doost et al., 2013]; execu-
tive function training for attention deficit hyperactivity disorder 
(ADHD), e.g. [Van der Oord et al., in press]; attentional bias modi-
fication training for alcohol abuse, e.g. [Schoenmakers et al., 2010]; 
motivational interviewing techniques in behaviour therapy inter-
ventions, e.g. [Geller and Dunn, 2011]). Other examples include 
interventions that use knowledge and principles gleaned from in-
hibitory learning and inhibitory regulation models in anxiety in 
order to optimize extinction learning [Craske, 2015].
Combining Traditional Diagnostic with Relevant  
Endophenotypes Approaches
It has become evident that existing diagnostic classification sys-
tems have notorious weaknesses that may be an obstacle for the 
development of improved alternative diagnostic approaches [Fava 
et al., 2014]. Targeting core psychological dysfunctions and pro-
cesses rather than sticking to traditional psychopathological syn-
dromes and the criteria of specific mental disorder (as defined in 
DSM-5) is seen as a promising additional strategy, closely linked to 
the endophenotype approach that has become a main topic in neu-
robiological research. Endophenotypes or intermediate phenotypes 
are specific clusters of symptoms that constitute building blocks or 
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intermediate processes for mental disorders and supposedly carry a 
more specific and consistent genetic load than the overall disorders 
that they contribute to [Skuse, 2001]. In the common diathesis-
stress models of psychopathology and mental disorders, endophe-
notypes arguably represent vulnerability factors or (bio-)markers 
for mental disorders rather than being indicators for the full-blown 
disorder. Such endophenotypes can often be related to specific 
functions in a cognitive psychology framework, such as memory, 
attention, executive functions, or others. In some domains, consid-
erable progress has already been made in the identification of 
meaningful cognitive endophenotypes over the past few decades. 
For instance, impulsivity as measured by a number of tasks and 
instruments is not only a promising core endophenotype for 
ADHD, but also for substance disorders and other externalizing 
disorders. Dysfunction in emotion dysregulation is involved in a 
variety of mood and anxiety disorders [Hofmann et al., 2012]. Au-
tobiographical memory biases may be involved in obsessive-com-
pulsive disorders, trauma and depression [Williams et al., 2007]. 
Executive function deficits including impaired working memory 
and inhibition and increased impulsivity are endophenotypic not 
only of ADHD but also of addiction, obsessive-compulsive disor-
ders and eating disorders [Robbins et al., 2011]. Repetitive negative 
thinking is a cognitive marker of mental disorders as diverse as de-
pression, anxiety disorders, bipolar disorder and psychosis [Ehring 
and Watkins, 2008]. It can be expected that future interventions 
will increasingly consist of evidence-based treatment programmes 
targeting specific psychological processes (e.g. memory specificity 
training for mood disorders and post-traumatic stress disorder 
(PTSD), executive function training in ADHD, addiction and eat-
ing disorders, attentional bias modification training for addiction 
and anxiety disorders) in place of school-of-thought-based or dis-
order-based interventions. Findings from such approaches might 
fit much better with a modular psychology framework and a di-
mensional endophenotype perspective than with a categorical, 
nomothetic view of mental disorders. However, it should be em-
phasized that the search for improved endophenotypes and match-
ing interventions should not be misunderstood as a departure from 
traditional psychopathology and traditional diagnostic concepts. 
Traditional diagnostic classification systems such as DSM-IV and 
DSM-5 will remain in the future – despite inherent weaknesses, 
representing the essential link between science and research on one 
side and clinical practice and the management of health care sys-
tems on the other. 
Focus on Understanding Why Psychotherapy is  
Efficacious and Effective
There is little doubt from a scientific perspective that CBTs and 
some other psychological interventions are effective, highly benefi-
cial and cost effective for a wide range of mental disorders and 
health conditions (see e.g. Health Technology Assessment reviews; 
[Roth and Fonagy, 1996; Butler et al., 2006]), such as anxiety, stress 
and trauma-related disorders, depressive and somatoform and 
pain disorders, personality disorders, substance use disorders and 
behavioural addictions, eating disorders and a number of child-
hood disorders [Hofmann and Smits, 2008]. For all these disorders, 
various variants of CBT have been established in clinical ran-
domized trials. There is also strong evidence for the efficacy of 
CBTs and other psychotherapeutic methods, at least as an adjuvant 
treatment, for psychotic and bipolar disorder [Jones et al., 2012a,b; 
van der Gaag et al., 2012; Hutton and Taylor, 2013]. Further, psy-
chotherapy is established for a wide range of somatic diseases and a 
range of health conditions for which behavioural factors play a sig-
nificant role in the initiation, maintenance and rehabilitation, such 
as cancer (e.g. [Fors et al., 2011]), cardiovascular disease (e.g. [Gul-
liksson et al., 2011]), metabolic disease and obesity (e.g. [Grilo et 
al., 2012]), and fibromyalgia [Kashikar-Zuck et al., 2012].
In addition, there are multiple systems regularly evaluating evi-
dence-based psychological therapy, such as the National Institute 
for Health and Clinical Excellence (NICE) Guidelines (www.nice.
org.uk), the APA/Division 12/Society for Science of Clinical Psy-
chology/SSCP platform or Cochrane reviews (www.cochrane.org). 
Despite this overwhelming level of evidence, there are, however, 
some notable problems that should be resolved in future research. 
Identifying Core Ingredients and Mechanisms of Action
Current systems of evaluating evidence-based psychotherapy 
focus on data supporting (psycho)therapeutic packages, while ne-
glecting the degree of empirical support for the theoretical basis of 
these packages. To delineate core ingredients and to identify mech-
anisms of action and therapeutic change, David and Montgomery 
[2011] proposed a new grid system for the evaluation of evidence-
based psychotherapy, proposing 9 categories, resulting from levels 
of evidence regarding 2 factors: (1) theory/mechanisms of change 
and (2) interventions (i.e. therapeutic package) derived from that 
theory. The proposed categories are not static, but based on the 
progress of research, allowing one form of psychotherapy to move 
from one category to another. On the level of the theoretical and 
mechanisms of change, it should be emphasized that this level does 
not necessarily refer to the aetiopathogenic mechanisms that have 
led to expression of the disorder or condition, but more generally 
to the assumed mechanism of change in the psychotherapeutic ap-
proach under study. Mediation and moderation analyses are typi-
cally involved in this kind of analysis. The hypothesized mediators 
and/or moderators should be specified in advance, based on scien-
tific clinical theories. The specific role of ‘placebo conditions’ 
[Kirsch, 1990] and non-specific ‘contextual’ factors, such as thera-
peutic alliance [Wampold, 2001], in psychotherapy should be em-
phasized. On the outcome level, analyses focus on the impact that a 
specific intervention has on a specific outcome or on a spectrum of 
outcomes (e.g. clinical conditions). The quality of the outcome 
analysis depends on the level of outcome specification, i.e.: (1) the 
clinical symptomatology (i.e. including primary and secondary 
symptom or diagnostic outcomes); (2) the general level of distress; 
and (3) the social functioning and quality of life to understand how 
the clinical condition(s) and/or interventions impact the real life of 
our clients. Cost-effectiveness considerations should be incorpo-
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rated as a standard, because even the best treatment with known 
mechanisms of action is unlikely to be used if it is too expensive 
[Sava et al., 2009]. 
Despite its claim as being scientifically based, current CBT ap-
proaches and manuals are not entirely consistent with novel basic 
and clinical research (i.e. neural underpinnings, fear circuitries, 
(epi-)genetic factors, developmental pathways, dynamic role of 
learning, extinction, avoidance, safety behaviour etc., [Etkin and 
Wager, 2007; Andrews et al., 2009; Arch and Craske, 2009; Gloster 
et al., 2011; Kircher et al., 2012]). Emotional responses like fear and 
anxiety are grounded in ‘complex systems’ that feed back to senso-
ry systems, heightening vigilance and information gathering (if a 
threat is expected or detected) and, importantly, prompting for ex-
ample defensive reflexive, autonomic, and motor responses that in 
evolutionary history acted directly to counter threats and escape 
punishments [Arch and Craske, 2009]. Comparative research 
across different forms of mental disorders is necessary to detect 
such core aspects of dysfunctions shared by all disorders in con-
trast to disorder-specific features [Etkin and Wager, 2007; Haber 
and Rauch, 2010; Lueken et al., 2011; Domschke and Deckert, 
2012] and to inform how therapeutic interventions can be opti-
mized, e.g. by component, mediator and moderator analyses. A 
better understanding of the basic mechanisms of mental disorders 
and their personal variations will guide the translational agenda of 
how evidence-based psychotherapy can be procedurally optimized, 
e.g. for more effective reduction of dysfunctional patterns of fear, 
anxiety and avoidance. Such research will also provide information 
on when best to intervene with which component (i.e. timing of 
interventions, add-on modules, and comorbidity issues). Here, 
there is a clear need of research in truly clinical samples or even 
clinical cohort samples, rather than in (psychology) students with 
heightened scores on a questionnaire. 
More rigorous designs are needed to investigate mediators of 
treatment outcome. Current findings are inconclusive. Little is 
known about the similarities, differences and specificity of the 
change processes across treatment modalities and paradigms. 
There is a clear need to examine how these treatments work and 
what accounts for the variability in outcomes. Unfortunately, few 
studies have measured the proposed mechanisms during treat-
ment, so it is unclear whether change in the supposed mediator 
precedes change in the outcome. For example, although most ther-
apists hold that change in cognitions is responsible for effects 
achieved with CBTs, there is still a surprisingly small number of 
studies that have directly tested for cognitive mediation (e.g. [Mey-
erbröker et al., 2013]). Most of the studies that focused on media-
tors of treatment outcome failed to assess whehter the mediator 
changed before the improvement occurred, meaning it was not 
possible to test questions of temporality, a critical component of 
mediation [Teachman, 2014].
Focus on Understanding and Tailoring Combined Treatments 
A controversial question is still the combination of drug and 
psychological treatment. Whereas there are typically beneficial ad-
ditional effects when psychotherapy is added to drug therapy, the 
reverse does not necessarily seem to be the case. A number of stud-
ies have investigated the combination of psychotherapy with anti-
depressant drugs or tranquilizers, but generally such pharmaco-
therapy did not enhance the effects of evidence-based psychothera-
py as stand-alone treatment (e.g. [Forand et al., 2013]). Given that 
many patients asking for psychotherapy have some form of past 
and/or concurrent medication and given the unfavourable cost-ef-
fectiveness ratio of combined treatment approaches, there is an ur-
gent need to answer this unresolved issue and to investigate the 
moderator role of concurrent therapies. There is little systematic 
research about how such medication affects psychotherapy and 
what clinicians and researchers should do in such situations. Unre-
solved core questions are: (1) Do past or only concomitant medica-
tion affect treatment response and the mechanism of action? What 
type and pattern of medication has an impact? (2) How frequent 
are particular patient constellations: Is the patient a non- or partial 
responder associated with appropriate or inappropriate psychop-
harmacotherapy? Would the patient profit more from stopping or 
changing (optimizing) medication? (for further questions see 
table  2). Currently, tapering off medication before inclusion or 
keeping the medication constant (combination treatment) are the 2 
major options, providing no further or more specific guidance. In-
tegration of psychological and pharmacological interventions may 
bear great promise for the treatment of some aspects of psychopa-
thology (particularly disordered memory processes); however, 
much more knowledge is needed on the exact boundary conditions 
for pharmacological intervention on specific psychological pro-
cesses. Increased knowledge along those lines should help to pave 
the way for interventions that combine psychological and biomedi-
cal techniques in an intelligent, science-based way and/or follow a 
clinically meaningful sequential strategy [Fava, 2000]. Further-
more, the development of empirically grounded strategies for 
switching between and within pharmacological and psychothera-
peutic treatments in case of non- or insufficient response is an im-
portant challenge for the future (e.g. [Gloster et al., 2015]). 
Exploring the Potential of Novel Technologies
Psychotherapy might profit in research and practice from a sys-
tematic exploration of e-health technologies. Beyond the option of 
providing improved and ecologically valid information about the 
patients’ behaviour in real life, they might allow optimizing essential 
components of the treatment outside the therapy setting. To make a 
better contribution to reducing the disease burden of mental disor-
ders, psychotherapy research might also systematically explore in-
ternet-based treatments and e-Mental health tools (e.g. to support 
‘real time’ clinical decision making to prevent treatment failure or 
relapse). In this field, 4 broad research areas can be distinguished 
(for a broader discussion see [Emmelkamp et al., 2014]): (1) research 
on how to apply the fact, in routine mental health care, that internet-
based treatments are efficacious; (2) further development of existing 
internet-based treatments; (3) the use of technological innovations, 
such as a move to the mobile phone, ‘serious gaming’ [Merry et al., 
2012], and the use of avatars; and (4) generic issues of dosage and 
feedback with the aim of reducing treatment failures. 
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Reducing Translational Barriers 
Although effective psychological treatments (CBTs) exist for 
many disorders, treatment rates are low [Wittchen et al., 2011] and 
are characterized by long time lapses (typically decades) between 
disorder onset and treatment [Wang et al., 2005; Gustavsson et al., 
2011; Wittchen et al., 2011]. Among the few patients treated, drug 
and particularly psychotherapy treatment are frequently inade-
quate or inappropriate. State of the art ‘CBTs’ as studied in rand-
omized controlled clinical trials (RCTs) are rarely applied, despite 
short- and long-term effect sizes that are larger than for other 
treatments of mental disorders. When applied, treatment charac-
teristics in routine care typically do not match the RCT manual 
specification or treatment guidelines in terms of type, length and 
content. The reasons for this unfortunate situation are only partly 
understood despite promising suggestions for how to change the 
situation by use of improved science-practice networks [Crawcour 
et al., 2012]. Increasing the ‘ecological validity’ and clinical utility 
of CBT programs by avoiding overly selective inclusion criteria and 
diagnostic fragmentation might provide guidance on how to deal 
with comorbid conditions and prior or concomitant drug treat-
ment and with patients not achieving full remission. 
Conclusion: Goals and Needs in Psychological and 
Psychotherapy Research
Great progress has been made over the past decade with regard 
to the identification of a range of options for how to develop an 
improved understanding of mental disorders and their aetiopatho-
genic pathways across the lifespan. At the same time, firmer evi-
dence has become available that CBTs and some other psychologi-
cal treatments are effective in most mental disorders and mental 
health problems. However, we still have only rudimentary knowl-
edge about the question of why people develop mental disorders. 
Our effective methods are far from being satisfactory and their 
translation into the community to reduce the burden of mental 
disorders overall is largely deficient. 
Given the established efficacy and benefits of psychotherapy and 
CBTs in particular, time has now come for concerted action to over-
come the current fragmentation of research areas and fields. It is 
time to launch a comprehensive research agenda with clinical trials, 
and basic and translational projects within an overall population-
based developmental framework covering all ages, instead of a 
smaller-scale, narrow research agenda. We have outlined a number 
Goals Challenges (advances needed)
Improved basic research aiming 
towards a better understanding  
of the basic mechanisms of  
behaviour initiation and  
maintenance
Analyses of basic psychological functions (i.e. attention) and processes (i.e. learning) and –  
even more pronounced – of cognitive factors of higher order (decision making, memory,  
impulsivity, motivation, etc.), including their neurobiological underpinnings.
Examining how psychological 
factors affect health-related  
behaviour
Research on how such psychological factors and mechanisms influence health-related  
behaviours, their initiation, maintenance and ‘spontaneous natural’ change, particularly with 
regard to determinants for their critical trajectories. Such research is seen as high priority for  
an improved basic understanding of mental health and mental disorders and normal versus 
dysfunctional behaviour.
Development over the lifespan Research that examines such domains over the lifespan and specifies how vulnerabilities and 
stress influence critical developmental trajectories to poor health and specific mental disorders 
in particular. There is a strong need for improved developmentally sensitive models of mental 
health over the whole lifespan but in particular in childhood and adolescence as the core  
high-risk period for onset of mental disorders.
Moderators and mediators 
involved in behaviour change 
(treatment)
Manifest research gaps exist with regard to the mechanisms, moderators and mediators in-
volved in behaviour change within the specific context of psychological interventions and in 
particular CBT. This involves core questions such as: What are the neural and neurobiological 
changes associated with CBT-induced change? What are active ingredients and mechanisms  
of effective and efficacious psychotherapy? 
Improved translation of basic  
and applied psychological  
research into application and  
practice
There is a considerable science-practice gap on various core levels of research
– Improved aetiopathogenetic research that systematically incorporates social-environmental 
context and determinants as well as the neural underpinnings, based on models of mental 
health development and mental disorders. 
– Improved diagnostic assessment procedures targeting the core aetiopathogenic processes, 
rather than simply targeting psychopathological features as specified in existing, although 
imperfect, diagnostic classificatory rules. 
– Improved clinical intervention research to gain a better understanding of CBTs by  
identifying the core active ingredients, core mechanisms. 
– «Improved targeted intervention modules for preventive and treatment purposes 
– Improved models and approaches of dissemination and translation to routine care.
Table 2. Goals and 
needs for future re-
search in psychological 
science
Wittchen/Härtling/HoyerVerhaltenstherapie 2015;25:98–109108
of propositions (table 3) for what type of action might be particular-
ly fruitful to substantially advance our understanding of mental dis-
orders and the way psychotherapy might help to reduce the burden. 
We have emphasized that psychological models of mental disorders 
can guide research into psychological and environmental factors that 
elicit and maintain mental disorders as well as interventions to reduce 
them. In this respect, 4 areas relevant for psychotherapy research need 
to be highlighted: (1) psychological interventions for mental disorders 
should increasingly target specific cognitive dysfunctions and specific 
mechanism and examine potential endophenotypes in addition to tra-
ditional psychopathological and diagnostic targets; (2) component 
analyses aiming at an optimal identification of core ingredients and 
the mechanisms of change should be used to improve efficacy and ef-
fectiveness of psychotherapy, as well as improved translation to rou-
tine care; (3) moderator and mediator analyses should be emphasized; 
and (4) psychotherapy research needs to broaden in terms of adoption 
of large-scale public health strategies and treatments that can be ap-
plied to more patients in a simpler and cost-effective way. 
As we have consistently argued throughout this article, the 
framework for guiding or organizing this comprehensive and con-
certed research agenda can, in our view, only be provided by the 
psychological sciences. 
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Gaps and needs in research on e-Mental health and innovation of mental health care 
It is not clear when and how each of the treatment formats of psychological treatments (individual; group; family; guided self-help;  
Internet-based) is able to help better.
A shift in outcome research is needed towards more focus on reaching the right target groups, realizing effects in populations  
instead of individuals, reductions in disease burden and quality of life and improvement of coverage of treatments.
For individual therapy generic issues of dosage and feedback with the aim of reducing treatment failures in the context of e-mental 
health should be further investigated.
A portfolio of models to deliver psychological treatments should be developed along with methods to examine these models from a 
public health point of view.
More research on applying and implementing e-mental health tools and Internet-based treatment for mental disorders in several  
specific fields is needed
Prevention of mental disorders and public health.
Treatment of mental disorders in primary care.
Treatment of mental disorders in specialized mental health care.
General medical settings.
New and better Internet-based treatments should be developed
Comparative research on different treatment formats and unguided self-help can help in answering which treatment format helps 
best in which context.
More research is needed on how and in which setting Internet-based treatments should be delivered.
Research should not only be aimed at common mental disorders, but also at bipolar and psychotic disorders.
Although there is already some research on cost effectiveness of Internet-based treatment, this should be expanded to get a full 
overview of the benefits.
Technological innovations in e-Mental health and Internet-based treatments can contribute considerably to the further development  
of these treatments
– Research on the use of mobile applications may advance the field considerably.
–  Ecological Momentary Assessment (EMA) is a promising new field that may have a large impact on Internet-based treatments 
but also on the field of psychology and psychiatry in general.
–  More research in other new technologies is needed: the development of telepsychiatry, the development of avatars as coaches in 
psychological interventions, virtual reality, and serious gaming.
Table 3. Gaps and 
needs in research on  
e-Mental health and 
 innovation of mental 
health care [Emmel-
kamp et al., 2014]
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